Shandong Buchang Pharmaceuticals (603858.SH) has spent 528 million yuan to repurchase 3.03% of its shares.
BuXiang Pharmaceuticals (603858.SH) announced that as of September 18, 2024, the company has completed the central competitive bidding...
Shandong Buchang Pharmaceuticals (603858.SH) announced that as of September 18, 2024, the company has repurchased a total of 33.5555 million shares through centralized bidding trading. The repurchased shares account for 3.03% of the company's total share capital. The highest purchase price was 17.44 yuan per share and the lowest purchase price was 14.16 yuan per share. The total amount paid for the repurchases so far is 528 million yuan (excluding transaction fees).
Related Articles
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.
A-share hot topics in the evening | NVIDIA invests $5 billion in Intel
Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.
A-share hot topics in the evening | NVIDIA invests $5 billion in Intel
Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
RECOMMEND
Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025
Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025
SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025
